Роль кандидозной биопленки при резистентной к антимикотикам кандидемии
Роль кандидозной биопленки при резистентной к антимикотикам кандидемии
Бразоль М.А., Карабельская И.В., Колбин А.С., Попов С.Д., Баиндурашвили А.Г., Климко Н.Н. Роль кандидозной биопленки при резистентной к антимикотикам кандидемии. Consilium Medicum. 2008; 10 (1): 53–57.
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Список литературы
1. Raad I. Intravascular-catheter-related infections. Lancet. 1998;351:893–8.
2. Mukherjee P, Zhou G, Munyon R et al. Candida biofilm: a well-designed protected environment. Med Mycol 2005;43(3):191–208.
3. Mukherjee P, Chandra J. Candida biofilm resistance. Drug Resist Updat. 2004;7(4–5):301–9.
4. Ascioglu S, Rex J, Pauw B et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplant: an internation consensus. CID. 2002;34:7–14.
5. Chandra J, Kuhn D, Mukherjee P et al. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol. 2001;183(18):5385–94.
6. Shin J, Kee S, Shin M et al. Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources. J Clin Microbiol. 2002;40(4):1244–8.
7. Mukherjee P, Zhou G, Munyon R, et al. Candida biofilm: a well-designed protected environment. Med Mycol. 2005;43(3):191–208.
8. Bachmann S, VandeWalle K, Ramage G et al. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob Agents Chemother. 2002;46(11):3591–6.
9. Chandra J, Kuhn D, Mukherjee P et al. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 2001;183(18):5385–94.
10. Nett J, Andes D. Candida albicans biofilm development, modeling a host-pathogen interaction. Curr Opin Microbiol 2006;9(4):340–5.
11. Kuhn D, Chandra J, Mukherjee P et al. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Immun. 2002;70(2):878–8.
12. Al-Fattani M, Douglas L. Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance. J Med Microbiol 2006;55(8):999–1008.
13. Andes D, Nett J, Oschel P et al. Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. Infect Immun 2004;72(10):6023–31.
14. Bachmann S, VandeWalle K, Ramage G et al. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob Agents Chemother 2002;46(11):3591–6.
15. Mukherjee P, Chandra J. Candida biofilm resistance. Drug Resist Updat 2004;7(4–5):301–9.
16. Chandra J, Mukherjee P, Leidich S et al. Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J Dent Res. 2001;80(3):903–8.
17. Ramage G, Vande Walle K, Wickes B et al. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother. 2001;45(9):2475–9.
18. Bachmann S, VandeWalle K, Ramage G, et al. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob Agents Chemother 2002;46(11):3591–6.
19. Kuhn D, George T, Chandra J et al. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 2002;46(6):1773–80.
20. Al-Fattani M, Douglas L. Penetration of Candida biofilms by antifungal agents. Antimicrob Agents Chemother 2004;48(9):3291–7.
21. Cocuaud C, Rodier M, Daniault G et al. Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms. J Antimicrob Chemother 2005;56(3):507–12.
22. Samaranayake Y, Ye J, Yau J, et al. In vitro method to study antifungal perfusion in Candida biofilms. J Clin Microbiol 2005;43(2):818–25.
23. Shuford J, Rouse M, Piper K et al. Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model. J Infect Dis 2006;194(5):710–3.
24. Shuford J, Piper K, Steckelberg J et al. In vitro biofilm characterization and activity of antifungal agents alone and in combination against sessile and planktonic clinical Candida albicans isolates. Diagn Microbiol Infect Dis 2007;57(3):277–81.
25. Seidler M, Salvenmoser S, Muller F. In vitro effects of micofungin against Candida biofilms on polystyrene and central venous catheter sections. Int J Antimicrob Agents 2006;28(6):568–73.
2. Mukherjee P, Zhou G, Munyon R et al. Candida biofilm: a well-designed protected environment. Med Mycol 2005;43(3):191–208.
3. Mukherjee P, Chandra J. Candida biofilm resistance. Drug Resist Updat. 2004;7(4–5):301–9.
4. Ascioglu S, Rex J, Pauw B et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplant: an internation consensus. CID. 2002;34:7–14.
5. Chandra J, Kuhn D, Mukherjee P et al. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol. 2001;183(18):5385–94.
6. Shin J, Kee S, Shin M et al. Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources. J Clin Microbiol. 2002;40(4):1244–8.
7. Mukherjee P, Zhou G, Munyon R, et al. Candida biofilm: a well-designed protected environment. Med Mycol. 2005;43(3):191–208.
8. Bachmann S, VandeWalle K, Ramage G et al. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob Agents Chemother. 2002;46(11):3591–6.
9. Chandra J, Kuhn D, Mukherjee P et al. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 2001;183(18):5385–94.
10. Nett J, Andes D. Candida albicans biofilm development, modeling a host-pathogen interaction. Curr Opin Microbiol 2006;9(4):340–5.
11. Kuhn D, Chandra J, Mukherjee P et al. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Immun. 2002;70(2):878–8.
12. Al-Fattani M, Douglas L. Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance. J Med Microbiol 2006;55(8):999–1008.
13. Andes D, Nett J, Oschel P et al. Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. Infect Immun 2004;72(10):6023–31.
14. Bachmann S, VandeWalle K, Ramage G et al. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob Agents Chemother 2002;46(11):3591–6.
15. Mukherjee P, Chandra J. Candida biofilm resistance. Drug Resist Updat 2004;7(4–5):301–9.
16. Chandra J, Mukherjee P, Leidich S et al. Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J Dent Res. 2001;80(3):903–8.
17. Ramage G, Vande Walle K, Wickes B et al. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother. 2001;45(9):2475–9.
18. Bachmann S, VandeWalle K, Ramage G, et al. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob Agents Chemother 2002;46(11):3591–6.
19. Kuhn D, George T, Chandra J et al. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 2002;46(6):1773–80.
20. Al-Fattani M, Douglas L. Penetration of Candida biofilms by antifungal agents. Antimicrob Agents Chemother 2004;48(9):3291–7.
21. Cocuaud C, Rodier M, Daniault G et al. Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms. J Antimicrob Chemother 2005;56(3):507–12.
22. Samaranayake Y, Ye J, Yau J, et al. In vitro method to study antifungal perfusion in Candida biofilms. J Clin Microbiol 2005;43(2):818–25.
23. Shuford J, Rouse M, Piper K et al. Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model. J Infect Dis 2006;194(5):710–3.
24. Shuford J, Piper K, Steckelberg J et al. In vitro biofilm characterization and activity of antifungal agents alone and in combination against sessile and planktonic clinical Candida albicans isolates. Diagn Microbiol Infect Dis 2007;57(3):277–81.
25. Seidler M, Salvenmoser S, Muller F. In vitro effects of micofungin against Candida biofilms on polystyrene and central venous catheter sections. Int J Antimicrob Agents 2006;28(6):568–73.
Авторы
М.А.Бразоль, И.В.Карабельская, А.С.Колбин, С.Д.Попов, А.Г.Баиндурашвили, Н.Н.Климко
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.